These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 23238632)

  • 1. Replacement therapy for bleeding episodes in factor VII deficiency. A prospective evaluation.
    Mariani G; Napolitano M; Dolce A; Pérez Garrido R; Batorova A; Karimi M; Platokouki H; Auerswald G; Bertrand AM; Di Minno G; Schved JF; Bjerre J; Ingerslev J; Sørensen B; Ruiz-Saez A; ;
    Thromb Haemost; 2013 Feb; 109(2):238-47. PubMed ID: 23238632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies.
    Napolitano M; Di Minno MN; Batorova A; Dolce A; Giansily-Blaizot M; Ingerslev J; Schved JF; Auerswald G; Kenet G; Karimi M; Shamsi T; Ruiz de Sáez A; Dolatkhah R; Chuansumrit A; Bertrand MA; Mariani G
    Haemophilia; 2016 Sep; 22(5):752-9. PubMed ID: 27338009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steps towards an effective treatment strategy in congenital factor VII deficiency.
    Mariani G; Lapecorella M; Dolce A
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S42-7. PubMed ID: 16427385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
    Key NS; Aledort LM; Beardsley D; Cooper HA; Davignon G; Ewenstein BM; Gilchrist GS; Gill JC; Glader B; Hoots WK; Kisker CT; Lusher JM; Rosenfield CG; Shapiro AD; Smith H; Taft E
    Thromb Haemost; 1998 Dec; 80(6):912-8. PubMed ID: 9869160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosing, efficacy, and safety of recombinant factor VIIa (rFVIIa) in pediatric versus adult patients: the experience of the Hemostasis and Thrombosis Research Society (HTRS) Registry (2004-2008).
    Neufeld EJ; Saxena K; Kessler CM; Cooper DL;
    Pediatr Blood Cancer; 2013 Jul; 60(7):1178-83. PubMed ID: 23335449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
    Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
    Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding symptoms at disease presentation and prediction of ensuing bleeding in inherited FVII deficiency.
    Di Minno MN; Dolce A; Mariani G;
    Thromb Haemost; 2013 Jun; 109(6):1051-9. PubMed ID: 23571462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of bleeding and hemorrhagic complications in surgical patients with inherited factor VII deficiency.
    Wiszniewski A; Szczepanik A; Misiak A; Bykowska K; Szopiński P
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):324-30. PubMed ID: 25688458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal.
    Mariani G; Konkle BA; Ingerslev J
    Haemophilia; 2006 Jan; 12(1):19-27. PubMed ID: 16409171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term prophylaxis in severe factor VII deficiency.
    Siboni SM; Biguzzi E; Mistretta C; Garagiola I; Peyvandi F
    Haemophilia; 2015 Nov; 21(6):812-9. PubMed ID: 25952977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B; Wiis J
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosing and effectiveness of recombinant activated factor VII (rFVIIA) in congenital haemophilia with inhibitors by bleed type and location: the experience of the Haemophilia and Thrombosis Research Society (HTRS) Registry (2004-2008).
    Young G; Cooper DL; Gut RZ;
    Haemophilia; 2012 Nov; 18(6):990-6. PubMed ID: 22631073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency.
    Huang WY; Kruskall MS; Bauer KA; Uhl L; Shaz BH
    Transfusion; 2004 Nov; 44(11):1562-6. PubMed ID: 15504160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful control of central nervous system bleeding in two newborns with severe factor VII deficiency using rFVIIa administered via Port-a-Cath.
    Karimi M
    Semin Hematol; 2008 Apr; 45(2 Suppl 1):S74. PubMed ID: 18544432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor VII deficiency: defining the clinical picture and optimizing therapeutic options.
    Lapecorella M; Mariani G;
    Haemophilia; 2008 Nov; 14(6):1170-5. PubMed ID: 19141157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation - the surgical STER.
    Mariani G; Dolce A; Batorova A; Auerswald G; Schved JF; Siragusa S; Napolitano M; Knudsen JB; Ingerslev J;
    Br J Haematol; 2011 Feb; 152(3):340-6. PubMed ID: 21158750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful prophylactic use of recombinant activated factor VII (rFVIIa) in a patient with congenital FVII deficiency and inhibitors to FVII.
    Tokgoz H; Caliskan U; Lavigne-Lissalde G; Giansily-Blaizot M
    Haemophilia; 2012 Jan; 18(1):e25-7. PubMed ID: 21973016
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of massive cecal bleeding in a 28-Year-old patient with homozygous factor V deficiency with activated factor VII.
    Petros S; Fischer J; Mössner J; Schiefke I; Teich N
    Z Gastroenterol; 2008 Mar; 46(3):271-3. PubMed ID: 18322882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The paradoxical association between inherited factor VII deficiency and venous thrombosis.
    Marty S; Barro C; Chatelain B; Fimbel B; Tribout B; Reynaud J; Schved JF; Giansily-Blaizot M
    Haemophilia; 2008 May; 14(3):564-70. PubMed ID: 18282149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.